{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:10:30Z","timestamp":1678558230181},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf00872863","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T15:39:06Z","timestamp":1104161946000},"page":"143-147","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma"],"prefix":"10.1007","volume":"13","author":[{"given":"Milan","family":"Slavik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.","family":"Kraut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald B.","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence E.","family":"Flaherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon K.","family":"Sondak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00872863_CR1","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/0006-2952(85)90335-1","volume":"34","author":"AD Brewer","year":"1985","unstructured":"Brewer AD, Minatelli JA, Plowman J, Paull KD, Narayanan VL: 5-(N-phenylcarboxyamido)-2-thiobarbituric acid (NSC 336628), a novel potential antitumor agent. Biochem Pharmacol 34:2047\u20132050, 1985.","journal-title":"Biochem Pharmacol"},{"key":"BF00872863_CR2","first-page":"45","volume":"62","author":"JS Driscoll","year":"1978","unstructured":"Driscoll JS, Melnick NR, Quinn FT, Lomax N, Davignon JP, Ing R, Abbott BJ, Congleton G, Dudeck L: Psychotropic drugs as potential antitumor agents: A selective screening study. Cancer Treat Rep 62:45\u201374, 1978.","journal-title":"Cancer Treat Rep"},{"key":"BF00872863_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00203538","volume":"5","author":"A Glover","year":"1987","unstructured":"Glover A, Chun HG, Kleinman LM, Cooney DA, Plowman J, Grieshaber CK, Malspeis L, Leyland-Jones B: Merbarone: An antitumor agent entering clinical trials. Invest New Drugs 5:137\u2013143, 1987.","journal-title":"Invest New Drugs"},{"key":"BF00872863_CR4","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/0006-2952(85)90368-5","volume":"34","author":"DA Cooney","year":"1985","unstructured":"Cooney DA, Covey JM, Kang GJ, Dalai M, McMahon JB, Johns DG: Initial mechanistic studies with merbarone (NSC 336628). Biochem Pharmacol 34: 3395\u20133398, 1985.","journal-title":"Biochem Pharmacol"},{"key":"BF00872863_CR5","first-page":"276","volume":"27","author":"DA Cooney","year":"1986","unstructured":"Cooney DA, Covey JM, Dalal M, Plowman J, Kensler TW, Sinha B, Johns DG: Mechanistic studies with merbarone (NSC 336628). Proc Am Assoc Cancer Res 27:276, 1986.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00872863_CR6","first-page":"328","volume":"29","author":"RK Johnson","year":"1988","unstructured":"Johnson RK, Hofman GA, Bartus HF, Mattem MR, Bartus JO, Mong SM, Mirabelli CK: Inhibition of Topoisomerase II by merbarone. Proc Am Assoc of Cancer Res 29:328, 1988.","journal-title":"Proc Am Assoc of Cancer Res"},{"key":"BF00872863_CR7","first-page":"2578","volume":"49","author":"FH Drake","year":"1989","unstructured":"Drake FH, Hofmann GA, Mong SM, Bartus JO, Hertzberg RP, Johnson RK, Mattern MR, Mirabelli CK:In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res 49:2578\u20132583, 1989.","journal-title":"Cancer Res"},{"key":"BF00872863_CR8","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1021\/bi00446a029","volume":"28","author":"FH Drake","year":"1989","unstructured":"Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK: Biochemical and pharmacological properties of P170 and P180 forms of topoisomerase II. Biochemistry 28:8154\u20138160, 1989.","journal-title":"Biochemistry"},{"key":"BF00872863_CR9","first-page":"155","volume":"255","author":"JC Jones","year":"1991","unstructured":"Jones JC, Stevnser T, Mattern MR, Bohr VA: Effect of specific enzyme inhibitors on replication, total genome DNA repair and on gene-specific DNA repair after UV irradiation in CHO cells. Mutation Research, DNA Repair Reports 255:155\u2013162, 1991.","journal-title":"Mutation Research, DNA Repair Reports"},{"key":"BF00872863_CR10","first-page":"5946","volume":"53","author":"M Chen","year":"1993","unstructured":"Chen M, Beck WT: Tenoposide-resistant CEM cells which express mutant DNA topoisomerase II \u03b11 when treated with non-complex-stabilizing inhibitors of the enzyme, display no cross-resistance and reveal aberrant functions of the mutant enzyme. Cancer Res 53:5946\u20135953, 1993.","journal-title":"Cancer Res"},{"key":"BF00872863_CR11","first-page":"191","volume":"29","author":"EH Kraut","year":"1988","unstructured":"Kraut EH, Grever MR, Staubus AE, Malspeis L: Phase I clinical trial of merbarone (NSC 336628). Proc Am Assoc Cancer Res 29:191, 1988.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00872863_CR12","first-page":"1151","volume":"50","author":"JJ Dimaggio","year":"1990","unstructured":"Dimaggio JJ, Warrell RP, Muindi J, Stevens YW, Lee SJ, Lowenthal DA, Haines I, Walsh TD, Balzer L, Yaldei S, Young CW: Phase I clinical and pharmacological study of merbarone. Cancer Res 50:1151\u20131155, 1990.","journal-title":"Cancer Res"},{"key":"BF00872863_CR13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00944194","volume":"10","author":"EH Kraut","year":"1992","unstructured":"Kraut EH, Bendetti J, Balcerzak SP, Doroshow JH: Phase II trial of merbarone in soft tissue sarcoma: A Southwest Oncology Group Study. Invest New Drugs 10:347\u2013349, 1992.","journal-title":"Invest New Drugs"},{"key":"BF00872863_CR14","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/07357909309046939","volume":"11","author":"DV Jones","year":"1993","unstructured":"Jones DV, Ajani JA, Winn R, Daugherty KR, Levin G, Krakoff IH: A phase II study of merbarone in patients with adenocarcinoma of the pancreas. Cancer Investigation 11:667\u2013669, 1993.","journal-title":"Cancer Investigation"},{"key":"BF00872863_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00000421-199308000-00010","volume":"16","author":"EH Kraut","year":"1993","unstructured":"Kraut EH, Fleming T, MacDonald JS, Spiridonidis CH, Bradof JE, Baker LH: Phase II trial of merbarone in pancreatic carcinoma. A Southwest Oncology Group Study. Am J Clin Oncol (CCT) 16:327\u2013328, 1993.","journal-title":"Am J Clin Oncol (CCT)"},{"key":"BF00872863_CR16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/85.5.388","volume":"85","author":"AY Chang","year":"1993","unstructured":"Chang AY, Kim K, Glick J, Anderson T, Karp D, Johnson D: Phase II study of taxol, merbarone and piroxantrone in stage IV non-small cell lung cancer: The Eastern Cooperative Oncology Group Results. J Nat Cancer Inst 85:388\u2013394, 1993.","journal-title":"J Nat Cancer Inst"},{"key":"BF00872863_CR17","first-page":"346","volume":"12","author":"M Mullane","year":"1993","unstructured":"Mullane M, Holder L, Zimmer W, Braud E, Kilton L, Kucuk O, Blough R, Lad T, French S, Caroll R, Weidner L: Phase II study of merbarone in non-small cell lung cancer. Proc ASCO 12:346, 1993.","journal-title":"Proc ASCO"},{"key":"BF00872863_CR18","first-page":"263","volume":"12","author":"KY Look","year":"1993","unstructured":"Look KY, Blessing JA, Williams L, Morris M: A Phase II trial of merbarone (NSC 336628) as salvage therapy for squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study. Proc ASCO 12:263, 1993.","journal-title":"Proc ASCO"},{"key":"BF00872863_CR19","first-page":"616","volume":"39","author":"MR Violante","year":"1993","unstructured":"Violante MR: Improved efficacy and reduced vasculitis with ultrafine dispersion formulation of merbarone. Proc Am Assoc Cancer Res 39:616, 1993.","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00872863_CR20","first-page":"103","volume":"46","author":"J Stratmann","year":"1991","unstructured":"Stratmann J: Synthesis and structure elucidation of single and multiple thionated barbituric acid derivatives (German). Pharmazie 46:103\u2013105, 1991.","journal-title":"Pharmazie"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00872863.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00872863\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00872863","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00872863.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T17:44:37Z","timestamp":1678556677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00872863"}},"subtitle":["A Southwest Oncology Group study"],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF00872863"],"URL":"https:\/\/doi.org\/10.1007\/bf00872863","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}